U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07243158) titled 'Randomized Controlled Study of Dragonfly System for Functional Mitral Regurgitation' on Nov. 17.
Brief Summary: To confirm the effectiveness and safety of the Dragonfly transcatheter mitral valve repair system for the treatment of chronic moderate to severe (3+) or severe (4+) functional mitral regurgitation (FMR) who remained clinically symptomatic after adequate treatment.
Study Start Date: Dec. 30
Study Type: INTERVENTIONAL
Condition:
Mitral Regurgitation Functional
Intervention:
DEVICE: DragonFly System
This group is allocated to use DragonFly System for edge-to-edge repair manufactured by Hangzhou Valgen Medtech Co., Ltd...